K Number
K141067
Device Name
VIVID T8/VIVID T8 PRO
Manufacturer
Date Cleared
2014-05-23

(29 days)

Product Code
Regulation Number
892.1550
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Vivid T8/Vivid T8 Pro is Multipurpose Cardiovascular System designed for cardiac and Shared Service Imaging, the system supports following applications: Fetal/OB, Abdominal, Pediatric, Small Organ, Cardiac, Peripheral Vascular, Musculoskeletal Superficial/Conventional, Adult Cephalic, Neonatal Cephalic, Transcranial, Transrectal, Transvaginal and Transesophageal.
Device Description
The Vivid T8/Vivid T8 Pro is the full featured general purpose diagnostic ultrasound system which consists of a mobile console that provides digital acquisition, processing and display capability. The user interface includes a computer keyboard, color LCD image display and touch panel.
More Information

Not Found

No
The summary does not mention AI, ML, or any related terms, and the description of the device and its capabilities is consistent with traditional ultrasound technology.

No
The device is described as a "diagnostic ultrasound system" and its intended use is for "imaging," which are diagnostic rather than therapeutic functions.

Yes

The device description explicitly states, "The Vivid T8/Vivid T8 Pro is the full featured general purpose diagnostic ultrasound system".

No

The device description explicitly states it is a "full featured general purpose diagnostic ultrasound system which consists of a mobile console," indicating it includes hardware components beyond just software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use/Indications for Use: The description clearly states the device is a "Multipurpose Cardiovascular System designed for cardiac and Shared Service Imaging." It lists various anatomical sites and applications, all related to imaging the human body. IVDs are used to examine specimens (like blood, urine, tissue) outside the body to provide information about a person's health.
  • Device Description: The description details a "diagnostic ultrasound system" that performs "digital acquisition, processing and display capability." This aligns with the function of an imaging device, not a device that analyzes biological samples.
  • Input Imaging Modality: The input is "Ultrasound," which is an imaging technique used on the body, not a method for analyzing biological specimens.
  • Anatomical Site: The listed anatomical sites are all parts of the human body that are imaged directly.
  • Lack of mention of analyzing biological samples: There is no mention of the device being used to test or analyze blood, urine, tissue, or any other biological specimen.

In summary, the Vivid T8/Vivid T8 Pro is a diagnostic imaging device that uses ultrasound to visualize structures within the body. This is distinct from an In Vitro Diagnostic device, which analyzes samples taken from the body.

N/A

Intended Use / Indications for Use

The Vivid T8/Vivid T8 Pro is Multipurpose Cardiovascular System designed for cardiac and Shared Service Imaging, the system supports following applications:
Fetal/OB, Abdominal, Pediatric, Small Organ, Cardiac, Peripheral Vascular, Musculoskeletal Superficial/Conventional, Adult Cephalic, Neonatal Cephalic, Transcranial, Transrectal, Transvaginal and Transesophageal.

Product codes

IYN, IYO, ITX

Device Description

The Vivid T8/Vivid T8 Pro is the full featured general purpose diagnostic ultrasound system which consists of a mobile console that provides digital acquisition, processing and display capability. The user interface includes a computer keyboard, color LCD image display and touch panel

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Ultrasound

Anatomical Site

Fetal/OB, Abdominal, Pediatric, Small Organ (breast, testes, thyroid), Cardiac (adult and pediatric), Peripheral Vascular, Musculoskeletal Superficial/Conventional, Adult Cephalic, Neonatal Cephalic, Transcranial, Transrectal, Transvaginal and Transesophageal.

Indicated Patient Age Range

Adult, Pediatric, Neonatal, Fetal

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The subject of this premarket submission, Vivid T8/Vivid T8 Pro, did not require clinical studies to support substantial equivalence.

Summary of Non-Clinical Tests:
Vivid T8/Vivid T8 Pro has been evaluated for acoustic output, biocompatibility, cleaning and disinfection effectiveness as well as thermal, electrical, electromagnetic, and mechanical safety, and have been found to conform with applicable medical device safety standards. The Vivid T8/Vivid T8 Pro complies with voluntary standards:

  1. AAMI/ANSI ES60601-1, Medical Electrical Equipment - Part 1 : General Requirements for Safety
  2. IEC60601-1-2, Medical Electrical Equipment -Part 1-2:General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility Requirements and Tests
  3. IEC60601-2-37, Medical Electrical Equipment -Part 2-37:Particular Requirements for the Safety of Ultrasonic Medical Diagnostic and Monitoring Equipment
  4. NEMA UD 3. Standard for Real Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment
  5. ISO10993-1, Biological Evaluation of Medical Devices- Part 1: Evaluation and Testing- Third Edition
  6. NEMA UD 2, Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment
  7. ISO14971, Application of risk management to medical devices
  8. NEMA, Digital Imaging and Communications in Medicine (DICOM) Set. (Radiology)

The following quality assurance measures are applied to the development of the system:

  • . Risk Analysis
  • . Requirements Reviews
  • Design Reviews .
  • . Testing on unit level (Module verification)
  • Integration testing (System verification) .
  • Performance testing (Verification) .
  • Safety testing (Verification) .
  • Simulated use testing (Validation) .
    Transducer material and other patient contact materials such as needle guidance kits are biocompatible.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K121063 GE Vivid S6/S5 BT12, K133034 GE LOGIQ F Series

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.1550 Ultrasonic pulsed doppler imaging system.

(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.

0

Image /page/0/Picture/7 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" intertwined in a stylized, cursive font. The letters are enclosed within a circular border. The logo is black and white.

K141067

GE Healthcare 510(k) Premarket Notification Submission

510(k) Summary

In accordance with 21 CFR 807.92 the following summary of information is provided:
Date:April 22, 2014
Submitter:GE Healthcare
9900 Innovation Dr
Wauwatosa, WI 53226
Primary Contact Person:Bryan Behn
Regulatory Affairs Manager
GE Healthcare
T:(414)721-4214
F:(414)918-8275
Secondary Contact Person:Jiawei ZHANG
Regulatory Affairs
GE Healthcare
T: +86 510 8527 8259
F: +86 510 8522 7347
Device: Trade Name:Vivid T8, Vivid T8 Pro
Common/Usual Name:Vivid T8, Vivid T8 Pro
Classification Names:Class II
Product Code:Ultrasonic Pulsed Doppler Imaging System. 21CFR 892.1550 90-
IYN Ultrasonic Pulsed Echo Imaging System, 21CFR 892.1560,
90-IYO Diagnostic Ultrasound Transducer, 21 CFR 892.1570,
90-ITX
Predicate Device(s):K121063 GE Vivid S6/S5 BT12
K133034 GE LOGIQ F Series
Device Description:The Vivid T8/Vivid T8 Pro is the full featured general purpose
diagnostic ultrasound system which consists of a mobile console
that provides digital acquisition, processing and display
capability. The user interface includes a computer keyboard,
color LCD image display and touch panel
Intended Use:Vivid T8/Vivid T8 Pro is Multipurpose Cardiovascular System
designed for cardiac and Shared Service Imaging, the system
supports following applications: Fetal/OB, Abdominal, Pediatric,
Small Organ, Cardiac, Peripheral Vascular, Musculoskeletal
Superficial/Conventional, Adult Cephalic, Neonatal Cephalic,
Transcranial, Transrectal, Transvaginal and Transesophageal

1

Image /page/1/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'G' and 'E' intertwined within a circular border. The letters and the border are solid black, creating a high-contrast image.

GE Healthcare 510(k) Premarket Notification Submission

Vivid T8/Vivid T8 Pro employs the same fundamental scientific Technology: technology as its predicate devices.

Comparison to Predicate Devices

Determination of Substantial Equivalence:

The Vivid T8 and T8 Pro systems are substantially equivalent to the predicate devices with regard to intended use, imaging capabilities, technological characteristics and safety and effectiveness.

| | | Proposed Device
Vivid T8/Vivid
T8 Pro | Predicate Device
Vivid S5/S6
(K121063) |
|---|---------------------------------------------------------------------------------------------------|---------------------------------------------|----------------------------------------------|
| | Indications and Clinical Applications: | | |
| • | Fetal/Obstetrics; | ✓ | ✓ |
| • | Abdominal/
GYNPediatric; | ✓ | ✓ |
| • | Small Organ (breast, testes,
thyroid); | ✓ | ✓ |
| • | Neonatal Cephalic; | ✓ | ✓ |
| • | Adult Cephalic; | ✓ | ✓ |
| • | Cardiac (adult and
pediatric); | ✓ | ✓ |
| • | Peripheral Vascular; | ✓ | ✓ |
| • | Musculo-skeletal
Conventional and
Superficial; | ✓ | ✓ |
| • | Urology (including
prostate); | ✓ | ✓ |
| • | Transesophageal; | ✓ | ✓ |
| • | Transrectal; | ✓ | ✓ |
| • | Transvaginal; | ✓ | ✓ |
| • | Intraoperative (abdominal,
thoracic, and vascular). | | ✓ |
| | Contact Type | | |
| • | Surface, Cavitary , TEE | ✓ | ✓ |
| | Image modes: | | |
| • | B; M; Color, Power,
PW& CW Doppler modes,
Color M-mode, Harmonic
imaging, Combined modes | ✓ | ✓ |
| | Transducers | | |
| • | 3S-RS | | ✓ |
| • | 5S-RS | | ✓ |
| • | 6S-RS | ✓ | ✓ |
| • | 7S-RS | | ✓ |
| • | 10S-RS | | ✓ |
| • | M4S-RS | | ✓ |

2

Image /page/2/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" in a stylized font, enclosed within a circle. There are decorative swirls or flourishes around the circle, adding to the logo's design.

510(k) Premarket Notification Submission

4C-RS
8C-RS
E8C-RS
8L-RS
9L-RS
12L-RS
i12L-RS
6Tc / 6Tc-RS
6T / 6T-RS
9T / 9T-RS
P2D
P6D
3Sc-RS
12S-RS
L6-12-RS(same transducer
as that on the
predicate LOGIQ
F Series
K133034)
Processing & Display features:
Image freeze,
Multipleimages, Pan
/Zoom, Image maps (color
& gray), Cine loop, Spatial
& temporal filters, L-R / T-
B image rev., LVO
Contrast, Digital
harmonics, TGC, Raw data
access, ATO/ASO,
Compound Imaging,
Speckle Reduction, B-
Flow, Blood Flow
Imaging, TSI, TVI/TT,
SI/SRI Stress, LOGIQ
View, Automated Function
Imaging (AFI), AutoEF,
CPI (coded phase
inversion)
Smart; Depth with synthetic
aperture, Clear Vessel,
Continuous Tissue;
Optimization (CTO),
Tissue Characteristic
Optimization (TCO)
Tested to meet Electrical
Safety, EMC and
Biocompatibility Standards
Track 3 (within FDA
limits)

510(k) Premarket Notification Submission

3

Image /page/3/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'GE' intertwined and enclosed within a circle. The logo is black and white.

GE Healthcare 510(k) Premarket Notification Submission

Summary of Non-Clinical Tests:

Vivid T8/Vivid T8 Pro has been evaluated for acoustic output, biocompatibility, cleaning and disinfection effectiveness as well as thermal, electrical, electromagnetic, and mechanical safety, and have been found to conform with applicable medical device safety standards. The Vivid T8/Vivid T8 Pro complies with voluntary standards:

    1. AAMI/ANSI ES60601-1, Medical Electrical Equipment - Part 1 : General Requirements for Safety
    1. IEC60601-1-2, Medical Electrical Equipment -Part 1-2:General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility Requirements and Tests
    1. IEC60601-2-37, Medical Electrical Equipment -Part 2-37:Particular Requirements for the Safety of Ultrasonic Medical Diagnostic and Monitoring Equipment
    1. NEMA UD 3. Standard for Real Time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment
    1. ISO10993-1, Biological Evaluation of Medical Devices- Part 1: Evaluation and Testing- Third Edition
    1. NEMA UD 2, Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment
    1. ISO14971, Application of risk management to medical devices
    1. NEMA, Digital Imaging and Communications in Medicine (DICOM) Set. (Radiology)

The following quality assurance measures are applied to the development of the system:

  • . Risk Analysis
  • . Requirements Reviews
  • Design Reviews .
  • . Testing on unit level (Module verification)
  • Integration testing (System verification) .
  • Performance testing (Verification) .
  • Safety testing (Verification) .

4

Image /page/4/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'G' and 'E' intertwined within a circular border. The letters are stylized and appear to be in a cursive font. The logo is black and white.

GE Healthcare 510(k) Premarket Notification Submission

  • Simulated use testing (Validation) .
    Transducer material and other patient contact materials such as needle guidance kits are biocompatible.

Summary of Clinical Tests:

The subject of this premarket submission, Vivid T8/Vivid T8 Pro, did not require clinical studies to support substantial equivalence.

GE Healthcare considers the Vivid T8/Vivid T8 Pro to be as safe, Conclusion: as effective, and performance is substantially equivalent to the predicate device(s).

Conclusion:

5

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/5/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized depiction of an eagle or bird-like figure with three curved lines representing its wings or body. The logo is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

May 23, 2014

GE Healthcare % Mr. Bryan Behn Regulatory Affairs Manager 9900 Innovation Drive WAUWATOSA WI 53226

Re: K141067

Trade/Device Name: Vivid T8, Vivid T8 Pro Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: April 22, 2014 Received: April 24, 2014

Dear Mr. Behn:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

This determination of substantial equivalence applies to the following transducers intended for use with the Vivid T8 and Vivid T8 Pro Diagnostic Ultrasound System, as described in your premarket notification:

Transducer Model Number

4C-RSE8C-RS
3Sc-RSL6-12-RS
8C-RSP2D
6S-RS6Tc-RS

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

6

Page 2-Mr. Behn

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note ' the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Smh.7)

for

Janine M. Morris Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

7

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

510(k) Number (if known) K141067

Device Name

Vivid T8/Vivid T8 Pro Diagnostic Ultrasound System

Indications for Use (Describe)

The Vivid T8/Vivid T8 Pro is Multipurpose Cardiovascular System designed for cardiac and Shared Service Imaging, the system supports following applications: Fetal/OB. Abdominal. Pediatric. Small Organ. Cardiac. Vascular. Adult Cephalic, Neonatal Cephalic, Musculoskeletal Superticial/Conventional, Transrectal, Transvaginal and Transesophageal.

Type of Use (Select one or both, as applicable)

2 Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

Form Approved: OMB No, 0910-0120

Explration Date: January 31, 2017

See PRA Statement below.

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

Sm.7)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW."

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

15

8

Diagnostic Ultrasound Indications for Use Form

Vivid T8/Vivid T8 Pro Ultrasound System

Intended Use: Ultrasound imaging, measurement and analysis of the human body as follows:

Clinical ApplicationMode of Operation
BMDoppler ModesCombinedHarmonicCoded
Anatomy/Region of InterestPWCWColorColor
MPowerModesImagingPulseOther
OphthalmicNNNNNNNNNNN
Fetal/OBNNNNNNNNNNN
Abdominal1NNNNNNNNNNN
PediatricNNNNNNNNNNN
Small Organ (specify)(2)NNNNNNNNNNN
Neonatal CephalicNNNNNNNNNNN
Adult CephalicNNNNNNNNNNN
Cardiac[3]NNNNNNNNNNN
Peripheral VascularNNNNNNNNNNN
Musculo-skeletal ConventionalNNNNNNNNNNN
Musculo-skeletal SuperficialNNNNNNNNNNN
Thoracic/Pleural (specify)NNNNNNNNNNN
Other (specify)NNNNNNNNNNN
Exam Type, Means of Access
TranscranialNNNNNNNNNNN
TransorbitalNNNNNNNNNNN
TransesophagealNNNNNNNNNNN
TransrectalNNNNNNNNNNN
TransvaginalNNNNNNNNNNN
Intraoperative (specify)
Intraoperative Neurological
Intravascular/Intraluminal
Intracardiac
Laparoscopic

[I] Abdominal includes GYN and Urological: Notes:

[2] Small Organ includes breast, testes, and thyroid;

[3] Cardiac is Adult and Pediatric;

[*] Combined modes are color/power Doppler with B-mode

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

Prescription Use (Per 21 CFR 801.109)

Page 2 of. I 0

9

Diagnostic Ultrasound Indications for Use Form

Vivid T8/Vivid T8 Pro with 4C-RS Transducer

Intended Use: Ultrasound imaging, measurement and analysis of the human body as follows:

Clinical ApplicationMode of Operation
BMDoppler ModesCombined
Modes*Harmonic
ImagingCoded
PulseOther
Anatomy/Region of InterestPWCWColorColor
MPower
OphthalmicPPPPPPPPP
Fetal/OBPPPPPPPPP
Abdominal[1]PPPPPPPPP
PediatricPPPPPPPPP
Small Organ (specify)[2]PPPPPPPPP
Neonatal Cephalic
Adult Cephalic
Cardiac[3]
Peripheral Vascular
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Thoracic/Pleural (specify)
Other (specify)
Exam Type, Means of Access
Transcranial
Transorbital
Transesophageal
Transrectal
Transvaginal
Intraoperative (specify)
Intraoperative Neurological
Intravascular/Intraluminal
Intracardiac
Laparoscopic

N = new indication; P = previously cleared by FDA (KI21063)

[1] Abdominal includes GYN and Urological; Notes:

[2] Small Organ includes breast, testes, and thyroid:

[3] Cardiac is Adult and Pediatric:

[1] Caralac is Addin and Pocial.right M, B/PWD, B/Color/PWD, B/PWD

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE UN ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

Prescription Use (Per 21 CFR 801.109)

Page 3 of 10

10

Diagnostic Ultrasound Indications for Use Form Vivid T8/Vivid T8 Pro with E8C-RS Transducer

Intended Use: Ultrasound imaging, measurement and analysis of the human body as follows:

Clinical ApplicationMode of Operation
Doppler Modes
Anatomy/Region of InterestBMPWCWColorColor MPowerCombined Harmonic ModesHarmonic ImagingCoded PulseOther
Ophthalmic
Fetal/OBPPPPPPPPP
Abdominal[1]PPPPPPPPP
Pediatric
Small Organ (specify)[2]
Neonatal Cephalic
Adult Cephalic
Cardiac[3]
Peripheral Vascular
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Thoracic/Pleural (specify)
Other (specify)
Exam Type, Means of Access
Transcranial
Transorbital
Transesophageal
TransrectalPPPPPPPPP
TransvaginalPPPPPPPPP
Intraoperative (specify)
Intraoperative Neurological
Intravascular/Intraluminal
Intracardiac
Laparoscopic

N = new indication; P = previously cleared by FDA (K121063)

[I] Abdominal includes GYN and Urological: Notes:

[2] Small Organ includes breast, testes, and thyroid

[3] Cardiac is Adult and Pediatric;

[*] Combined modes are B/M, B/Color M, B/PWD, B/Color/PWD, B/PWD

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

Prescription Use (Per 21 CFR 801.109)

Page 4 of 10

11

Diagnostic Ultrasound Indications for Use Form Vivid T8/Vivid T8 Pro with 3Sc-RS Transducer

Intended Use: Ultrasound imaging, measurement and analysis of the human body as follows:

| Clinical Application

Anatomy/Region of InterestMode of Operation
BMDoppler ModesCombined
ModesHarmonic
ImagingCoded
PulseOther
PWCWColorColor
MPower
Ophthalmic
Fetal/OB
Abdominal[1]PPPPPPPPPPP
PediatricPPPPPPPPPPP
Small Organ (specify)[2]
Neonatal Cephalic
Adult CephalicPPPPPPPPPPP
Cardiac[3]PPPPPPPPPPP
Peripheral Vascular
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Thoracic/Pleural (specify)
Other (specify)
Exam Type, Means of Access
TranscranialNNNNNNNNNN
Transorbital
Transesophageal
Transrectal
Transvaginal
Intraoperative (specify)
Intraoperative Neurological
Intravascular/Intraluminal
Intracardiac
Laparoscopic

N = new indication; P = previously cleared by FDA (K121063)

[I] Abdominal includes GYN and Urological Notes:

[2] Small Organ includes breast, testes, and thyroid

[3] Cardiac is Adult and Pediatric

*] Combined modes are B/M, B/Color M, B/PWD, B/Color/PWD, B/PWD

(PLEASE DO NOT WRITE BELOW THIS LINE · CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

Prescription Use (Per 21 CFR 801.109)

Page 5 of 10

12

Diagnostic Ultrasound Indications for Use Form Vivid T8/Vivid T8 Pro with L6-12-RS Transducer

Intended Use: Ultrasound imaging, measurement and analysis of the human body as follows:

Clinical ApplicationMode of Operation
Anatomy/Region of InterestBMPWCWColorColor
MPowerCombined
ModesHarmonic
ImagingCoded
PulseOther
Ophthalmic
Fetal/OB
Abdominal[1]NNNNNNNNNNN
PediatricPNPPPNPPPN
Small Organ (specify)[2]PNPPPNPPPN
Neonatal CephalicNNNNNNNNNN
Adult Cephalic
Cardiac[3]
Peripheral VascularPNPPPNPPPN
Musculo-skeletal ConventionalPNPPPNPPPN
Musculo-skeletal SuperficialPNPPPNPPPN
Thoracic/Pleural (specify)
Other (specify)
Exam Type, Means of Access
Transcranial
Transorbital
Transesophageal
Transrectal
Transvaginal
Intraoperative (specify)
Intraoperative Neurological
Intravascular/Intraluminal
Intracardiac
Laparoscopic

N = new indication; P = previously cleared by FDA (K133034)

[ I ] Abdominal includes GYN and Urological: Notes:

[2] Small Organ includes breast, testes, and thyroid;

[3] Cardiac is Adult and Pediatric;

(* ) Combined modes are B/M, B/Color M, B/PWD, B/Color/PWD, B/PWD

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IP NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radlological Health (OIR)

Prescription Use (Per 21 CFR 801.109)

Page 6 of 10

13

Diagnostic Ultrasound Indications for Use Form

Vivid T8/Vivid T8 Pro with 8C-RS Transducer

Intended Use: Ultrasound imaging, measurement and analysis of the human body as follows:

| Clinical Application

Anatomy/Region of InterestMode of Operation
BMDoppler ModesCombined
ModesHarmonic
ImagingCoded
PulseOther
PWCWColorColor
MPower
Ophthalmic
Fetal/OB
Abdominal[1]
PediatricPPPPPPPPP
Small Organ (specify)[2]
Neonatal CephalicPPPPPPPPP
Adult Cephalic
Cardiac[3]
Peripheral VascularPPPPPPPPP
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Thoracic/Pleural (specify)
Other (specify)
Exam Type, Means of Access
Transcranial
Transorbital
Transesophageal
Transrectal
Transvaginal
Intraoperative (specify)
Intraoperative Neurological
Intravascular/Intraluminal
Intracardiac
Laparoscopic

N = new indication; P = previously cleared by FDA (K121063)

[1] Abdominal includes GYN and Urological: Notes:

[2] Small Organ includes breast, testes, thyroid;

[3] Cardiac is Adult and Pediatric;

Combined modes are B/M, B/Color M, B/PWD, B/Color/PWD. B/PWD

(PLEASE DO NOT WRITE BELOW THIS LINE . CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

Prescription Use (Per 21 CFR 801.109)

Page 7 of !0

14

Diagnostic Ultrasound Indications for Use Form Vivid T8/Vivid T8 Pro with P2D Transducer

Intended Use: Ultrasound imaging, measurement and analysis of the human body as follows:

Clinical ApplicationMode of Operation
Anatomy/Region of InterestBMDoppler ModesCombined
ModesHarmonic
ImagingCoded
PulseOther
PWCWColorColor
MPower
Ophthalmic
Fetal/OB
Abdominal(1)
Pediatric
Small Organ (specify)[2]
Neonatal Cephalic
Adult Cephalic
Cardiac[3]P
Peripheral Vascular
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Thoracic/Pleural (specify)
Other (specify)
Exam Type, Means of Access
Transcranial
Transorbital
Transesophageal
Transrectal
Transvaginal
Intraoperative (specify)
Intraoperative Neurological
Intravascular/Intraluminal
Intracardiac
l aparoscopic

N = new indication; P = previously cleared by FDA (K121063)

[1] Abdominal includes GYN and Urological; Notes:

[2] Small Organ includes breast, testes, thyroid;

[3] Cardiac is Adult and Pediatric:

[3] Calulac is Adult and Pealants.
[*] Combined modes are B/M, B/Color M, B/PWD, B/Color/PWD, B/PWD

(PLEASE DO NOT WRITE BELOW THIS LINE · CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

Prescription Use (Per 21 CFR 801.109)

. Page 8 of 10

15

Diagnostic Ultrasound Indications for Use Form Vivid T8/Vivid T8 Pro with 6S-RS Transducer

Intended Use: Ultrasound imaging, measurement and analysis of the human body as follows:

Clinical ApplicationMode of Operation
Anatomy/Region of InterestBMPWCWDoppler Modes
ColorColor
MPowerCombined
ModesHarmonic
ImagingCoded
PulseOther
Ophthalmic
Fetal/OBPPPPPPPPPP
Abdominal(1)PPPPPPPPPP
PediatricPPPPPPPPPP
Small Organ (specify)(2)
Neonatal CephalicPPPPPPPPPP
Adult Cephalic
Cardiac(3)PPPPPPPPPP
Peripheral Vascular
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Thoracic/Pleural (specify)
Other (specify)
Exam Type, Means of Access
Transcranial
Transorbital
Transesophageal
Transrectal
Transvaginal
Intraoperative (specify)
Intraoperative Neurological
Intravascular/Intraluminal
Intracardiac
โ จทลากระดดเต

N = new indication; P = previously cleared by FDA

[1] Abdominal includes GYN and Urological; Notes:

[2] Small Organ includes breast, testes, thyroid;

[3] Cardiac is Adult and Pediatric:

[*] Combined modes are B/M, B/Color M, B/PWD, B/Color/PWD, B/PWD

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IP NEEDED)

Concurrence of CDRH, Office of In Vitro Dlagnostics and Radiological Health (OIR)

Prescription Use (Per 21 CFR 801.109)

Page 9 of 10

16

Diagnostic Ultrasound Indications for Use Form Vivid T8/Vivid T8 Pro with 6Tc-RS Transducer

Intended Use: Ultrasound imaging, measurement and analysis of the human body as follows:

Clinical ApplicationMode of Operation
BMDoppler ModesCombined HarmonicCoded
Anatomy/Region of InterestPWCWColorColor
MPowerModes*ImagingPulseOther
Ophthalmic
Fetal/OB
Abdominal[1]
Pediatric
Small Organ (specify)[2]
Neonatal Cephalic
Adult Cephalic
Cardiac[3]PPPPPPPPP
Peripheral Vascular
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Thoracic/Pleural (specify)
Other (specify)
Exam Type, Means of Access
Transcranial
Transorbital
TransesophagealPPPPPPPPP
Transrectal
Transvaginal
Intraoperative (specify)
Intraoperative Neurological
Intravascular/Intraluminal
Intracardiac
Laparoscopic

N = new indication; P = previously cleared by FDA (K121063)

[1] Abdominal includes GYN and Urological Notes:

[2] Small Organ includes breast, testes, thyroid

[3] Cardiac is Adult and Pediatric

[1] Combined modes are B/M, B/Color M, B/PWD. B/Color/PWD, B/PWD

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)

Prescription Use (Per 21 CFR 801.109)

Page 10 of 10

(Division Sign-Off) Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety 510(k) Number_